News

Why accreditation?

Annual IMS Institute survey finds generics level at 86%

Fast-tracked product is acclaimed by FDA as well as its developer, Kaléo

2014 EMD Serono Specialty Digest: managing adherence programs are a sought-after service

Company also announces a 10-year agreement with Salesforce.com

Entry comes as FDA-healthcare provider dispute continues over Zogenix’ Zohydro version of extended-release hydrocodone

Service connects McKesson industry clients to PI's network of e-prescribing and EHRs

Guideline anticipates final FDA guidance to be issued later this year

Annual survey tracks rapid evolution in a critical pharma market

Better adherence could save $337 billion in healthcare costs

Cost-cutting will continue while marketplace demands a higher level of data quality from pharma

Pfizer waits for a response from AstraZeneca

First of many meetings to come that are required by the Drug Supply Chain Security Act

Society will publish a 'Drug Shortages Prevention Plan' to attack root causes

Global industry will spend $8.36 billion on cold chain logistics this year

A rising flow of new, expensive therapies is transforming relationships among payers and providers. Manufacturers will have to react nimbly to the changes

Both pharmacological and economic factors drive the decision to use these technologies

A new federal law sets the US industry's agenda for years to come; efforts globally are moving ahead

Optimized multichannel communications will prevent illness and save lives

Five-year agreement will cover Phase II-IV projects, and some Phase I work

New market-access concerns drive an expansion in this combination of financial and medical concerns

Is a Pfizer-AstraZeneca merger in the offing?

Grant Hodgkins, ex of Alcon Labs, joins Jay Crowley, ex-FDA senior advisor, at the firm

A potential unintended consequence of the Physicians Sunshine Act: Some job-candidate interviews will become a publicly accessible record